TIQ-15
CAS No. 1380336-17-3
TIQ-15( TIQ-15 | TIQ 15 | TIQ15 )
Catalog No. M11572 CAS No. 1380336-17-3
TIQ-15 is a potent and selective CXCR4 antagonist, inhibits attachment of X4 HIV-1IIIB virus in MAGI-CCR5/CXCR4 cells with IC50 of 3 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1053 | Get Quote |
|
| 50MG | 2142 | Get Quote |
|
| 100MG | 2790 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTIQ-15
-
NoteResearch use only, not for human use.
-
Brief DescriptionTIQ-15 is a potent and selective CXCR4 antagonist, inhibits attachment of X4 HIV-1IIIB virus in MAGI-CCR5/CXCR4 cells with IC50 of 3 nM.
-
DescriptionTIQ-15 is a potent and selective CXCR4 antagonist, inhibits attachment of X4 HIV-1IIIB virus in MAGI-CCR5/CXCR4 cells with IC50 of 3 nM; inhibits calcium release in Chem-1 cells with IC50 of 3 nM, shows no cross-activity in a panel of chemokine receptor assays in both CXCR and CCR types.
-
In Vitro——
-
In Vivo——
-
SynonymsTIQ-15 | TIQ 15 | TIQ15
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorChemokine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1380336-17-3
-
Formula Weight364.537
-
Molecular FormulaC23H32N4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESNCCCCN(C[C@H]1CC2=C(C=CC=C2)CN1)[C@@H]3C4=NC=CC=C4CCC3
-
Chemical NameN1-(((R)-1,2,3,4-tetrahydroisoquinolin-3-yl)methyl)-N1-((S)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Truax VM, et al. ACS Med Chem Lett. 2013 Sep 5;4(11):1025-30.
2. Yesim A. Tahirovic, et al. ACS Med. Chem. Lett., 2018, 9 (5), pp 446-451.
molnova catalog
related products
-
(S)-CCX-777
A small-molecule partial agonist of CXCR7 (ACKR3).
-
GSK812397
GSK812397 is a potent, selective, noncompetitive, orally available antagonist of CXCR4 receptor.
-
AF-399 42016530
A potent CCR4 antagonist that blocked CCL22- and CCL17-mediated migration of human peripheral blood CD4+CD25+ Treg and Th2 cells ex-vivo and murine Tregs in-vivo.
Cart
sales@molnova.com